Sunday, March 22, 2026

 

Stable, fast, mass-producible: Breakthrough in light-based data connections



New technology facilitates manufacture of optical microchips for efficient data transmission



Karlsruher Institut für Technologie (KIT)

The compact modulator enables fast and energy-efficient data transmission and can be produced at low cost. 

image: 

The compact modulator enables fast and energy-efficient data transmission and can be produced at low cost.

view more 

Credit: Hugo Larocque, EPFL





Similar to modern computer chips, the modulator can be manufactured using established semiconductor processes. The researchers combine lithium tantalate — a material that guides light particularly well and serves as the heart of the modulator — with a proven chip manufacturing technique from microelectronics. To date, these two technologies have never been used together. For the first time now, they enable reliable mass production.

 

Mass-Production Techniques Proven Millions of Times

Light modulators convert electrical signals into light pulses which already are the basis for high-speed internet and ideal for applications with massive data streams, such as artificial intelligence training. Yet, the manufacturing process is new: “The key advance lies in the copper electrodes and the way we manufacture them,” says Professor Christian Koos, Head of KIT’s Institute of Photonics and Quantum Electronics (IPQ). This is because copper conducts signals better than the gold used so far. At the same time, copper enables very smooth surfaces, which makes the component more efficient because less energy is lost.  The copper electrodes can be manufactured using a process that has already been tested millions of times in the production of electronic computer chips. Unlike earlier methods, this results in an almost mirror-smooth surface that allows the optical microchips to be easily connected to electronic chips. This not only makes modulators easier to manufacture, but also allows them to be integrated  better into existing electronic systems.

 

Highest Data Rates with Stable Operation

Tests conducted by the KIT team show: “The modulator enables very high data rates and, above all, runs stably without us having to constantly correct the settings,” says Alexander Kotz, also from IPQ. This is a major advance, as constant readjustment during continuous operation is costly, complicates transmission systems, and consumes energy Considering the millions of such components used in data centers and AI clusters, this is a particularly critical point. 

 

The modulator reaches data rates of over 400 gigabits per second, which corresponds to the simultaneous transmission of around 80,000 HD streams (at 5 megabits per second per stream) or of 8 complete HD movies. “We are working at the limits of what is technically possible today. With more powerful control electronics, we could even increase the data rates,” Kotz adds. “Fast, economical, reliable, and manufacturable on an industrial scale — this combination makes the technology attractive, especially for data centers and AI clusters that are already suffering from bottlenecks in data exchange between processors,” emphasizes Koos.

 

In close partnership with society, KIT develops solutions for urgent challenges – from climate change, energy transition and sustainable use of natural resources to artificial intelligence, sovereignty and an aging population. As The University in the Helmholtz Association, KIT unites scientific excellence from insight to application-driven research under one roof – and is thus in a unique position to drive this transformation. As a University of Excellence, KIT offers its more than 10,000 employees and 22,800 students outstanding opportunities to shape a sustainable and resilient future. KIT – Science for Impact.

 

 

Prototype breath tests spot bacterial infections in minutes




American Chemical Society





Infectious diseases are a major cause of death worldwide, and diagnosing bacterial infections remains a challenge in medicine. And doing so reliably is more important than ever, given the increasing frequency of antibiotic resistance. Now, research published in ACS Central Science could help healthcare professionals non-invasively diagnose bacterial infections, using breath-based tests. Initial experiments demonstrated the approach in animals with pneumonia and infections in the bloodstream, muscles and bones. 

“In designing this study, we were motivated by a developing trend in clinical practice, whereby patients and providers want answers right away that will inform treatment decisions,” says David Wilson, a corresponding author of the study. “If a patient visits the Emergency Room or Acute Care clinic, we hope that he or she can be diagnosed with an acute bacterial infection as efficiently as possible." 

Doctors currently rely on blood tests, imaging, cultures and molecular diagnostics to identify the cause of infections, but these tools are limited because they are slow, non-specific or expensive. The start to a potential solution could be the long-used breath test for Helicobacter pylori, a bacterium that causes a common stomach infection. The original test works when a person drinks a liquid containing traceable substances metabolized by H. pylori. Then the person exhales into a device that measures labeled carbon dioxide in their breath, indicating the infection is present. Inspired by this test, Wilson, Kiel Neumann, Marina López-Álvarez and colleagues set out to expand the technology’s capabilities to detect a broader range of bacterial infections. 

For their prototype, the team tested sugar and sugar alcohols tagged with carbon-13, a traceable form of carbon that bacteria metabolize but human cells largely ignore. In lab experiments, the researchers identified several of these compounds that bacteria convert into carbon-13-labeled carbon dioxide. Then they analyzed the labeled gas using a simple technique called nondispersive infrared spectroscopy.  

When mice with infections such as pneumonia and bone, muscle, or blood infections received intravenous injections of these tagged compounds, the animals’ breath quickly showed elevated levels of the labeled carbon dioxide. Although the breath testing protocol was not optimized in this study, the researchers say they typically saw elevated carbon-13-labeled breath signals in infected animals within the first 10 minutes of metabolite administration and breath sampling. In contrast, the breath of healthy mice showed little to no carbon-13. 

In one infection model for E. coli, the amount of labeled carbon dioxide in the breath decreased during antibiotic treatment as bacterial levels went down, suggesting the method could also be used to monitor how well treatments are working. 

Because breath-test instruments are portable and breath signals appear within minutes after the traceable carbon-13 is administered, the test could potentially deliver results faster than current methods. In addition, the sugar and sugar alcohols used are considered safe for humans, and the researchers say this approach could eventually become a tool for diagnosing bacterial infections. 

The authors acknowledge funding from the National Institutes of Health and the Cystic Fibrosis Foundation. 

The authors have filed a U.S. patent related to this work. 

The paper’s abstract will be available on March 18 at 8 a.m. Eastern time here: http://pubs.acs.org/doi/abs/10.1021/acscentsci.5c01995 

### 

The American Chemical Society (ACS) is a nonprofit organization chartered by the U.S. Congress. ACS’ mission is to advance the broader chemistry enterprise and its practitioners for the benefit of Earth and all its people. The Society is a global leader in promoting excellence in science education and providing access to chemistry-related information and research through its multiple research solutions, peer-reviewed journals, scientific conferences, e-books and weekly news periodical Chemical & Engineering News. ACS journals are among the most cited, most trusted and most read within the scientific literature; however, ACS itself does not conduct chemical research. As a leader in scientific information solutions, its CAS division partners with global innovators to accelerate breakthroughs by curating, connecting and analyzing the world’s scientific knowledge. ACS’ main offices are in Washington, D.C., and Columbus, Ohio. 

Registered journalists can subscribe to the ACS journalist news portal on EurekAlert! to access embargoed and public science press releases. For media inquiries, contact newsroom@acs.org. 

Note: ACS does not conduct research but publishes and publicizes peer-reviewed scientific studies. 

Follow us: X, formerly Twitter | Facebook | LinkedIn | Instagram  

 

Snail-derived compound could be a safer anticoagulant compared to heparins



American Chemical Society

For more than a century, heparin has been the go-to anticoagulant to prevent harmful blood clots in blood vessels or the heart from forming or getting larger. However, a major side effect is an increased risk of excessive bleeding, even from minor injuries like small cuts on the skin. In ACS Central Science, researchers report the discovery of a snail-derived compound that blocks clot formation while still preserving bleeding control in mouse models. 

Blood clots are natural temporary bandages that seal wounds and stop bleeding. These helpful clots — called hemostatic clots — speed healing to injuries like cuts to the skin. But a harmful type of clot called a thrombus can form inside blood vessels and the heart, blocking blood flow and causing severe pain and tissue damage. Deep vein thrombosis (DVT) occurs when these long-lasting clots form in the legs and don’t dissolve like they should. If they break away and move to other parts of the body, thrombi can cause strokes, shortness of breath and possibly death. Although heparin and other blood thinners help prevent thrombi, these anticoagulants also interfere with normal clotting (hemostasis) and raise the risk of excessive bleeding. So, Mingyi Wu and colleagues looked for a safer, naturally occurring anticoagulant that only targets thrombus formation. 

After analyzing numerous mollusk compounds, the researchers identified CCG, a new glycosaminoglycan (a type of complex sugar) from the snail Camaena cicatricosa. Although part of CCG’s molecular structure is similar to heparin, the sugar sequence that heparin uses to attach to one of its binding partners is missing in CCG. The researchers hypothesized that these differences could make CCG a safer anticoagulant. 

In tests with human plasma, CCG inhibited thrombus formation and had no effect on hemostasis. In mouse models of DVT, CCG administered by injection also reduced the incidence of thrombi DVT and, unlike heparin, did not increase bleeding risk. Further testing revealed that CCG prevents the assembly of an enzyme (iFXase) that is active in thrombus formation but not hemostasis. 

Although more research is needed, these initial results suggest that this snail-derived compound could be developed into a safer anticoagulant compared with heparins, the authors say. 

The authors acknowledge funding from the Strategic Priority Research Program of the Chinese Academy of Sciences (CAS), the National Natural Science Foundation of China, Yunnan Fundamental Research Projects, the State Key Laboratory of Phytochemistry and Natural Medicines, Kunming Institute of Botany CAS, the Science and Technology Plan Project of Yunnan Province, the Yunnan Clinical Research Center for Obstetric and Gynecological Diseases, and the Yunnan Revitalization Talent Support Program "Young Talent" Projects. 

The paper’s abstract will be available on March 18 at 8 a.m. Eastern time here: http://pubs.acs.org/doi/abs/10.1021/acscentsci.5c02230  

### 

The American Chemical Society (ACS) is a nonprofit organization founded in 1876 and chartered by the U.S. Congress. ACS is committed to improving all lives through the transforming power of chemistry. Its mission is to advance scientific knowledge, empower a global community and champion scientific integrity, and its vision is a world built on science. The Society is a global leader in promoting excellence in science education and providing access to chemistry-related information and research through its multiple research solutions, peer-reviewed journals, scientific conferences, e-books and weekly news periodical Chemical & Engineering News. ACS journals are among the most cited, most trusted and most read within the scientific literature; however, ACS itself does not conduct chemical research. As a leader in scientific information solutions, its CAS division partners with global innovators to accelerate breakthroughs by curating, connecting and analyzing the world’s scientific knowledge. ACS’ main offices are in Washington, D.C., and Columbus, Ohio. 

Registered journalists can subscribe to the ACS journalist news portal on EurekAlert! to access embargoed and public science press releases. For media inquiries, contact newsroom@acs.org. 

Note: ACS does not conduct research but publishes and publicizes peer-reviewed scientific studies. 

Follow us: Facebook | LinkedIn | Instagram

 

Experiment reaches critical temperature to unlock search for dark matter



The operating system reached its coldest operating temperature, hundreds of times colder than outer space



University of Minnesota

SuperCDMS 

image: 

University of Minnesota researchers are working on the design of the low background shield, which creates a zone free of the trace radioactivity that could overwhelm the faint dark matter signal. Photo by Greg Stewart/SLAC National Accelerator Laboratory

view more 

Credit: Greg Stewart/SLAC National Accelerator Laboratory




MINNEAPOLIS / ST. PAUL (03/18/2026) — University of Minnesota Twin Cities researchers working on the Super Cryogenic Dark Matter Search (SuperCDMS) experiment are part of a team who successfully cooled the experiment to its base temperature—the temperature required for the superconducting detectors to become operational, which is hundreds of times colder than outer space.

Reaching base temperature marks a major transition for SuperCDMS, from construction and installation to commissioning and science operations. For SuperCDMS, that temperature is thousandths of a degree above absolute zero, where atomic and molecular motion ceases.

The experiment is designed to detect dark matter particles—mysterious particles that make up 85 percent of all matter in the Universe—that are already passing through Earth. Dark matter remains strange and illusive but tremendously important to our understanding of nature, from the most fundamental particles to origins and evolution of the Universe.

“Getting to base temperature is a major milestone in a years-long campaign to build a low-background facility capable of housing our sensitive cryogenic solid state detectors,” said Priscilla Cushman, a professor in the University of Minnesota School of Physics and Astronomy and the Spokesperson of SuperCDMS. “At these extremely low temperatures, our installed detectors can now scan a whole new region of parameter space where the lightest dark matter particles may be lurking.”

The University of Minnesota team designed, procured, and assembled the low background shield that protects the detectors from trace radioactivity and neutrons produced by high-energy cosmic rays in the cavern walls. The four-meter tall, four-meter-diameter cylindrical enclosure is made of layers of ultra-pure lead to stop the gammas and high-density polyethylene to moderate the neutrons. 

In addition to major roles in the installation and cooldown of the experiment, University of Minnesota researchers have developed new reconstruction algorithms and analysis techniques designed to rapidly extract dark matter signals from the data that will be flowing in a few months. The group is at the forefront of the science effort, with the help of School of Physics and Astronomy Assistant Professor Yan Liu, who is the Analysis Working Group Chair for the experiment.

The SuperCDMS experiment is sited at SNOLAB, a research facility located roughly 6,800 feet underground in an active nickel mine near Sudbury, Ontario. Buried at this depth, the experiment is protected from cosmic rays and other background particles that could drown out the faint signals scientists are trying to observe.

With base temperature achieved, the collaboration will move into detector commissioning, a months-long process of turning on, calibrating and optimizing each detector channel. Beyond dark matter, SuperCDMS will allow scientists to study rare isotopes, probe energies no one has measured before and maybe uncover entirely new kinds of particle interactions.

The SuperCDMS experiment is a joint project of the U.S. Department of Energy Office of Science, the U.S. National Science Foundation, the Canada Foundation for Innovation and the Natural Sciences and Engineering Research Council of Canada.

In addition to Cushman and Liu, the University of Minnesota team includes postdoctoral researchers Shubham Pandey and Himangshu Neog, research scientist Scott Fallows, and graduate students, Zachary Williams, Elliott Tanner and Chi Cap—all from the School of Physics and Astronomy.

For more information about the SuperCDMS experiment and collaboration, visit the SLAC National Accelerator Laboratory website. Read the news release on the SLAC website.